Abstract
“Tyrosine kinase inhibitors” (TKI) are small molecules responsible for selectively inhibiting cellular pathways involved in cell proliferation or migration. These molecules have been developed as alternative therapy for refractory or minimal responsive cancers to standard treatments. In this chapter, TKI currently used for anaplastic thyroid cancer, medullary thyroid cancer and/or refractory differentiated thyroid cancer will be described.
Keywords: Tyrosine kinase, Tyrosine Kinase Inhibitors (TKI), growth factor receptors.
Related Journals
Current Dentistry
Current Traditional Medicine
Adolescent Psychiatry
New Emirates Medical Journal
Current Radiopharmaceuticals
Recent Patents on Anti-Cancer Drug Discovery
Current Medicinal Chemistry - Anti-Cancer Agents
Current Cancer Therapy Reviews
Clinical Cancer Drugs
Anti-Cancer Agents in Medicinal Chemistry
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents